Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Zomedica's gross profit for the twelve months ending Jun 30, 2026 was $24.13M, up 22.6% year over year. For fiscal 2025 it was $21.68M, up 13.6% from the year before. The highest annual figure on record is $21.68M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.68M | +13.6% |
| FY2024 | Dec 31, 2024 | $19.09M | +10.2% |
| FY2023 | Dec 31, 2023 | $17.32M | +28.6% |
| FY2022 | Dec 31, 2022 | $13.47M | +341.0% |
| FY2021 | Dec 31, 2021 | $3.05M | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.04M | +29.5% |
| Q1 FY2026 | Mar 31, 2026 | $5.48M | +24.4% |
| Q4 FY2025 | Dec 31, 2025 | $7.17M | +29.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.44M | +7.4% |
| Q2 FY2025 | Jun 30, 2025 | $4.67M | +7.0% |
| Q1 FY2025 | Mar 31, 2025 | $4.41M | +7.0% |
| Q4 FY2024 | Dec 31, 2024 | $5.55M | +9.4% |
| Q3 FY2024 | Sep 30, 2024 | $5.06M | +16.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.36M | +7.8% |
| Q1 FY2024 | Mar 31, 2024 | $4.12M | +7.4% |
| Q4 FY2023 | Dec 31, 2023 | $5.07M | +20.5% |
| Q3 FY2023 | Sep 30, 2023 | $4.36M | +24.2% |
| Q2 FY2023 | Jun 30, 2023 | $4.05M | +34.7% |
| Q1 FY2023 | Mar 31, 2023 | $3.84M | +40.0% |
| Q4 FY2022 | Dec 31, 2022 | $4.21M | +37.6% |
| Q3 FY2022 | Sep 30, 2022 | $3.51M | +70120.0% |
| Q2 FY2022 | Jun 30, 2022 | $3.01M | – |
| Q1 FY2022 | Mar 31, 2022 | $2.74M | +34150.0% |
| Q4 FY2021 | Dec 31, 2021 | $3.06M | – |
| Q3 FY2021 | Sep 30, 2021 | $5.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$20.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $8.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
See a number that looks wrong?